Form 4 for ABEO ABEONA THERAPEUTICS INC.
Accepted 2022-03-16 00:00:00 ET · period of report 2022-03-14 · accession 0001493152-22-006976 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-03-16 | 2022-03-14 | ABEO | Vazzano Joseph Walter | CFO | A - Grant | $0.00 | +200.0K | 200.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common stock | 2022-03-14 | A | A | 200,000 | $0.00 | 200,000 | D | — | — | (F1) The restricted stock will vest 25% on each of March 14, 2023, March 14, 2024, March 14, 2025 and March 14, 2026. |